HKSE - Delayed Quote HKD

XUNFEIHEALTH (2506.HK)

120.200
-3.700
(-2.99%)
At close: 4:08:33 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
733,984
733,984
556,125
471,860
372,452
Cost of Revenue
329,900
329,900
241,471
241,191
184,722
Gross Profit
404,084
404,084
314,654
230,669
187,729
Operating Expense
524,983
524,983
499,192
470,108
290,433
Operating Income
-120,899
-120,899
-184,538
-239,439
-102,704
Net Non Operating Interest Income Expense
278
278
6,749
2,547
-1,088
Pretax Income
-172,016
-172,016
-186,915
-244,100
-110,970
Tax Provision
-34,380
-34,380
-32,691
-35,505
-21,569
Net Income Common Stockholders
-132,600
-132,600
-144,842
-208,595
-89,401
Diluted NI Available to Com Stockholders
-132,600
-132,600
-144,842
-208,595
-89,401
Basic EPS
-1.51
-1.16
-1.20
-1.73
-0.74
Diluted EPS
-1.51
-1.16
-1.20
-1.73
-0.74
Basic Average Shares
120,878.233
113,862
120,878.233
120,878.233
120,878.233
Diluted Average Shares
120,878.233
113,862
120,878.233
120,878.233
120,878.233
Total Expenses
854,883
854,883
740,663
711,299
475,155
Net Income from Continuing & Discontinued Operation
-132,600
-132,600
-144,842
-208,595
-89,401
Normalized Income
-91,545.080
-91,545.080
-137,237.032
-202,353.386
-83,729.350
Interest Income
6,418
6,418
7,960
3,137
1,807
Interest Expense
6,140
6,140
1,211
590
2,895
Net Interest Income
278
278
6,749
2,547
-1,088
EBIT
-165,876
-165,876
-185,704
-243,510
-108,075
EBITDA
-117,951
-117,951
-143,744
-189,278
-71,132
Reconciled Cost of Revenue
329,900
329,900
241,471
241,191
184,722
Reconciled Depreciation
47,925
47,925
41,960
54,232
36,943
Net Income from Continuing Operation Net Minority Interest
-132,600
-132,600
-144,842
-208,595
-89,401
Total Unusual Items Excluding Goodwill
-51,310
-51,310
-9,217
-7,304
-7,040
Total Unusual Items
-51,310
-51,310
-9,217
-7,304
-7,040
Normalized EBITDA
-66,641
-66,641
-134,527
-181,974
-64,092
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-10,255.080
-10,255.080
-1,612.032
-1,062.386
-1,368.350
12/31/2021 - 12/30/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade